Vanguard Personalized Indexing Management
BEAM icon

Vanguard Personalized Indexing Management’s Beam Therapeutics BEAM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Sell
9,219
-691
-7% -$20.9K ﹤0.01% 1678
2026
Q1 		$236K Buy
+9,910
New +$275K ﹤0.01% 1738
2025
Q1 		– Sell
-8,155
Closed -$202K – 1853
2024
Q4 		$202K Buy
+8,155
New +$208K ﹤0.01% 1523
2024
Q2 		– Sell
-7,630
Closed -$252K – 1703
2024
Q1 		$252K Buy
+7,630
New +$238K 0.01% 1344
2023
Q4 		– Sell
-8,993
Closed -$216K – 1570
2023
Q3 		$216K Buy
+8,993
New +$241K 0.01% 1272

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Personalized Indexing Management's BEAM Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Beam Therapeutics (BEAM) stake by 7% in Q2 2026, selling an estimated $20.9K and leaving 9,219 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #1678.

Vanguard Personalized Indexing Management first reported a position in BEAM in Q3 2023 and has held it in 5 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Vanguard Personalized Indexing Management held 9,219 shares of Beam Therapeutics worth $316K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 691 Beam Therapeutics shares in Q2 2026, an estimated $20.9K.
  • Beam Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1678 holding.
  • Vanguard Personalized Indexing Management first reported a position in Beam Therapeutics in Q3 2023 and has held it in 5 quarters since.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.